Analysis of type T1 and T2 cytokines in patients with prostate cancer

被引:1
|
作者
Filella, X
Alcover, J
Zarco, MA
Beardo, P
Molina, R
Ballesta, AM
机构
[1] Hosp Clin Barcelona, Canc Res Unit, Dept Clin Biochem, Inst Invest Biomed August Pi I Sunyer, Barcelona 08036, Spain
[2] Hosp Clin Barcelona, Dept Urol, Inst Invest Biomed August Pi I Sunyer, Barcelona 08036, Spain
来源
PROSTATE | 2000年 / 44卷 / 04期
关键词
prostate cancer; cytokine; Th1-Th2; paradigm;
D O I
10.1002/1097-0045(20000901)44:4<271::AID-PROS2>3.0.CO;2-G
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. It has been proposed that a dysregulation in the balance between type T1 (IL-2, IFN-gamma) and type T2 (IL-4, IL-10) cytokines may be implicated in the development of cancer. METHODS. We determined the expression of IL-2, IL-4, IL-10, and IFN-gamma in CD4 and CD8 lymphocytes by flow cytometry in 12 patients with prostate cancer and in 7 healthy subjects. In addition to the basal expression of these cytokines, their expression was also determined, following stimulation of lymphocytes with PMA (phorbol 12-mystirate 13 acetate) and ionomycin. RESULTS. The basal expression of cytokines was scarce, while following stimulation this increased markedly. On the other hand, there was a dysregulation in the balance between T1 and T2 lymphocytes in patients with prostate cancer. To this effect, in relation to healthy subjects, we observed an increase in IL-10 expression and a decrease in IL-2 expression. CONCLUSIONS. The disequilibrium observed in the balance between type T1 and type T2 cytokines may be implicated in the evolution of neoplastic disease. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 50 条
  • [21] CLINICOPATHOLOGICAL FEATURES OF THE TIS, T1, T2 RECTAL CANCER
    Iwasaki, Shunto
    Kudo, Shin-ei
    Kouyama, Yuta
    Ichimasa, Katsuro
    Misawa, Masashi
    Miyachi, Hideyuki
    Kondo, Kotaro
    Sasabe, Keisuke
    Semba, Shigenori
    Morita, Yuriko
    Shiina, Osamu
    Miyata, Yuki
    Takashina, Yuki
    Mochizuki, Kenichi
    Sato, Yuta
    Ogawa, Yushi
    Sakurai, Tatsuya
    Maeda, Yasuharu
    Hayashi, Takemasa
    Wakamura, Kunihiko
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB522 - AB522
  • [22] T1 and T2 Hypopharyngeal Cancer Treatment With Laser Microsurgery
    Karatzanis, Alexander D.
    Psychogios, George
    Waldfahrer, Frank
    Zenk, Johannes
    Hornung, Joachim
    Velegrakis, George A.
    Iro, Heinrich
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (01) : 27 - 33
  • [23] THE T1 AND T2 REPRESENTABILITY CONDITIONS
    Braams, Bastiaan J.
    Percus, Jerome K.
    Zhao, Zhengji
    REDUCED-DENSITY-MATRIX MECHANICS - WITH APPLICATION TO MANY-ELECTRON ATOMS AND MOLECULES, 2007, 134 : 93 - 101
  • [24] Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients
    Kim, Young-Woo
    Eom, Bang Wool
    Kook, Myeong-Cherl
    Kim, Han-Seong
    Kim, Mi-Kyung
    Hwang, Hai-Li
    Chandra, Vishal
    Poojan, Shiv
    Song, Yura
    Koh, Jae-Soo
    Bae, Chang-Dae
    Ro, Jungsil
    Hong, Kyeong-Man
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2015, 47 : e193 - e193
  • [25] Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients
    Young-Woo Kim
    Bang Wool Eom
    Myeong-Cherl Kook
    Han-Seong Kim
    Mi-Kyung Kim
    Hai-Li Hwang
    Vishal Chandra
    Shiv Poojan
    Yura Song
    Jae-Soo Koh
    Chang-Dae Bae
    Jungsil Ro
    Kyeong-Man Hong
    Experimental & Molecular Medicine, 2015, 47 : e193 - e193
  • [26] T1 and T2 alterations in the brains of patients with hepatic cirrhosis
    Vymazal, J
    Babis, M
    Brooks, RA
    Filip, K
    Dezortova, M
    Hrncarkova, H
    Hajek, M
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1996, 17 (02) : 333 - 336
  • [27] Simultaneous acquisition for T2 - T2 Exchange and T1 - T2 correlation NMR experiments
    Montrazi, Elton T.
    Lucas-Oliveira, Everton
    Araujo-Ferreira, Arthur G.
    Barsi-Andreeta, Mariane
    Bonagamba, Tito J.
    JOURNAL OF MAGNETIC RESONANCE, 2018, 289 : 63 - 71
  • [28] RADIATION-THERAPY FOR T1 AND T2 PROSTATE-CANCER - PROSTATE-SPECIFIC ANTIGEN AND DISEASE OUTCOME
    ZAGARS, GK
    POLLACK, A
    UROLOGY, 1995, 45 (03) : 476 - 483
  • [29] Palladium-103 brachytherapy for clinical T1/T2 prostate carcinomas
    Dattoli, MJ
    Wallner, KE
    Cash, JC
    Ross, RE
    Koval, JM
    Sorace, RA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 221 - 221
  • [30] External beam radiotherapy for stage T1/T2 prostate cancer: How does it stack up?
    Pollack, A
    Zagars, GK
    UROLOGY, 1998, 51 (02) : 258 - 264